IP Library Granted Patent US 12,390,487
Granted Patent B2
US 12,390,487 · App. 17/601,144 · Granted Aug 19, 2025

Antiseptic skin prep composition

Inventors: Avanti D. Dahiwadkar (Bangalore, IN); Matthew T. Scholz (Woodbury, MN)
Assignee: Solventum Intellectual Properties Company
A61K31/785A61K9/0014A61K31/14A61K31/155A61K31/444A61K47/10A61K47/22A61K47/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,390,487
App. No.
17/601,144
Granted
Aug 19, 2025
Kind
B2
Abstract

The disclosed antiseptic composition has improved stability, flow control and tinting ability is provided. The antiseptic composition comprises a cationic antiseptic, an anionic tinting agent, a polymer that serves as a stabilizer and preferably a viscosity builder, an alcohol-based solvent and optionally a plasticizer and viscosity builder.

Claims (36)

1. An antiseptic skin prep composition comprising:

(a) cationic excipient consisting only of a cationic antiseptic agent;

(b) anionic colorant;

(c) a non-ionic polyvinyl pyrrolidone polymer or copolymer; and

(d) C 1 -C 4 alcohol-based solvent,

wherein the antiseptic skin prep composition exhibits no visible precipitation when stored in a sealed inert barrier container having an internal diameter of 4.5 cm at 23 deg C. for at least 17 days.

2. The antiseptic skin prep composition as claimed in claim 1 , wherein the cationic antiseptic agent is present in the range of 0.1-2.5% by weight of the antiseptic skin prep composition.

3. The antiseptic skin prep composition of claim 1 , wherein the anionic colorant is present in the range of 0.01-0.1% by weight of the antiseptic skin prep composition.

4. The antiseptic skin prep composition of claim 1 , wherein the non-ionic polyvinyl pyrrolidone polymer or copolymer is present in the range of 0.1 to 10% by weight of the antiseptic skin prep composition.

5. The antiseptic skin prep composition of claim 1 , wherein the concentration of anionic colorant to non-ionic polyvinyl pyrrolidone polymer or copolymer is in the ratio 1:1 to 1:1000.

6. The antiseptic skin prep composition of claim 1 , comprising at least 60% by weight of a lower alcohol.

7. The antiseptic skin prep composition of claim 1 , wherein the cationic antiseptic agent is selected from a group of chlorhexidine salts, polyhexamethylene biguanide salts, octenidine salts, alexidine salts, benzethonium salts, and combinations thereof.

8. The antiseptic skin prep composition of claim 1 , wherein the anionic colorant is selected from a group of anionic dyes including FD & C Red No. 3, FD&C Yellow No. 6, FD&C Blue No. 1, D&C Yellow 10, Brilliant Blue, D&C green and Carmoisine.

9. The antiseptic skin prep composition of claim 1 , wherein the non-ionic polyvinyl pyrrolidone polymer or copolymer is selected from a group of polyvinyl pyrrolidone, copolymers of polyvinyl pyrrolidone and vinyl acetate, copolymer of polyvinyl pyrrolidone and butene, or combinations thereof.

10. The antiseptic skin prep composition of claim 1 , wherein the non-ionic polyvinyl pyrrolidone polymer is polyvinyl pyrrolidone.

11. The antiseptic skin prep composition of claim 1 , wherein the weight average molecular weight of the non-ionic polyvinyl pyrrolidone polymer or copolymer is 100,000-3,000,000 g/mol.

12. The antiseptic skin prep composition of claim 1 , wherein the C 1 -C 4 alcohol-based solvent is selected from a group of isopropyl alcohol, ethanol, n-propanol or combinations thereof.

13. An antiseptic skin prep solution of claim 1 , characterized by a viscosity of 1 to 100 cp when measured using a Brookfield DV2T viscometer, spindle LV-02 at 23 C.

14. The antiseptic skin prep composition of claim 1 , further comprising a plasticizer.

15. The antiseptic skin prep composition of claim 14 , wherein the plasticizer is glycerol.

16. The antiseptic skin prep composition of claim 1 , characterized as stable without any visible precipitate for at least 6 months at a temperature of 40 deg C.

17. A kit comprising:

an antiseptic skin prep composition of claim 1 , and

gauze, foam, or prepping solution dispenser.

18. A kit comprising,

a cationic excipient consisting only of a cationic antiseptic agent and non-ionic polyvinyl pyrrolidone polymer or copolymer provided as a solution; and

an anionic colorant provided separate from the solution,

wherein the solution and the anionic colorant are mixed just prior to use and remain stable without precipitation for at least 5 mins at 23 deg C.

19. A process of preparing an antiseptic skin prep composition of claim 1 , the method comprising:

mixing until dissolved the following:

an anionic colorant;

a cationic antiseptic agent;

a non-ionic, polyvinyl pyrrolidone polymer or copolymer;

a C 1 -C 4 alcohol; and

water.

20. The antiseptic skin prep composition of claim 1 , wherein the non-ionic, polyvinyl pyrrolidone polymer or copolymer prevents or postpones precipitation of a complex between the cationic antiseptic agent and the anionic colorant for at least 17 days at 23 deg C.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2021
From: DAHIWADKAR, AVANTI D.; SCHOLZ, MATTHEW T.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 057688/0115 →
Priority Claims (1)
IN 201941013830 · Apr 5, 2019 · national
Continuity (1)
Related Publication 20220193119A1 · Jun 23, 2022
References Cited (16)
US 7422388B2 · Tufts · 2008 [cited by applicant]
US 8436050B2 · Modak · 2013 [cited by applicant]
US 9821066B2 · Dokken · 2017 [cited by applicant]
US 20040116551A1 · Terry · 2004 [cited by examiner]
US 20070253909A1 · Magallon · 2007 [cited by examiner]
US 20070254854A1 · Magallon · 2007 [cited by applicant]
US 20120237452A1 · Colomer · 2012 [cited by applicant]
US 20140261454A1 · Dokken · 2014 [cited by examiner]
US 20160213001A1 · Parthasarathy · 2016 [cited by examiner]
US 20170014358A1 · Tuffley · 2017 [cited by applicant]
WO WO2006029255 · 2006 [cited by applicant]
WO WO2009068144 · 2009 [cited by applicant]
WO WO2013074860 · 2013 [cited by applicant]
Glycerol; https://www.google.com/search?q=glycerol+also+known+as; site accessed Jul. 2024 (Year: 2007). [cited by examiner]
‘N-Tert-Octylacrylamide’, PubChem, create date Mar. 26, 2005 (Mar. 26, 2005) retrieved from the internet on Jun. 30, 2020 (Jun. 30, 2020) at <https //pubchem ncbj nlm nihgovycompound/N-Tert-Octylacrylamide>. [cited by applicant]
International Search report for PCT International Application No. PCT/IB2020/053173 mailed on Aug. 27, 2020, 4 pages. [cited by applicant]